Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Ono Pharmaceutical Co., Ltd. is engaged in production, purchase, and sale of pharmaceutical and diagnostic reagents focusing on prescription pharmaceuticals. Its products include respiratory, digestive, urinary, chemotherapy, hormone, vitamins, and metabolic drugs. The company was established by... 
Surperformance© rating of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More about the company
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Full-screen chart
Financials ( JPY)
Sales 2014 149 575 M
EBIT 2014 -
Net income 2014 21 633 M
Finance 2014 128 974 M
Yield 2014 2,21%
Sales 2015 151 425 M
EBIT 2015 -
Net income 2015 20 341 M
Finance 2015 131 745 M
Yield 2015 2,21%
PER 2014 39,41
PER 2015 44,49
EV / Sales 2014 5,56x
EV / Sales 2015 5,47x
Capitalization 960 457 M
More Financials
Latest news on ONO PHARMACEUTICAL CO., LT
04/10 ONO PHARMACEUTICAL : Patent Issued for Compound Having Detrusor Muscle-Contracti..
03/27 ONO PHARMACEUTICAL CO., LTD. : ex-dividend day for final dividend
03/24 ONO PHARMACEUTICAL : FORXIGA® (dapagliflozin) receives regulatory approval in Ja..
03/06 ONO PHARMACEUTICAL CO., LTD. : ONO establishes an innovative research network ca..
02/19 ONO PHARMACEUTICAL CO., LTD. : "Method of Treating of Gastroesophageal Reflux Di..
01/29 ONO PHARMACEUTICAL CO., LTD. : "Methods of Producing Anamorelin Hydrochloride Ha..
2013 ONO PHARMACEUTICAL CO., LTD. : ONO Files for Regulatory Approval of "Nivolumab (..
2013 ONO PHARMACEUTICAL CO., LTD. : FDA Advisory Committee Recommends the Investigati..
2013 ONO PHARMACEUTICAL CO., LTD. : Clinical Trial Application submitted for Phase I ..
2013 ONO PHARMACEUTICAL CO., LTD. : AstraZeneca and Ono Enter Co-promotion Agreement ..
2013 ONO PHARMACEUTICAL CO., LTD. : Approval for Additional Indication of Onoact® 50 ..
2013 ONO PHARMACEUTICAL CO., LTD. : Results of Phase II/III Study of ONO-2745/CNS 705..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
ONO PHARMACEUTICAL CO., LT : Income Statement Evolution
More Financials
EPS Revisions
ONO PHARMACEUTICAL CO., LT : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF